Lamivudine

In the US, Lamivudine (lamivudine systemic) is a member of the drug class nucleoside reverse transcriptase inhibitors (NRTIs) and is used to treat Hepatitis B, HIV Infection, Nonoccupational Exposure and Occupational Exposure.

US matches:

• Lamivudine


• Lamivudine Solution


• Lamivudine/Zidovudine


• Lamivudine and zidovudine


• Lamivudine (3TC)

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J05AF05

CAS registry number (Chemical Abstracts Service)

0134678-17-4

Chemical Formula

C8-H11-N3-O3-S

Molecular Weight

229

Therapeutic Category

Antiviral agent, HIV reverse transcriptase inhibitor

Chemical Names

(-)-1-((2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine (WHO)

2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-,(2R-cis)-

4-Amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxythiolan-5-yl]pyrimidin-2(1H)-on (IUPAC)

Foreign Names

• Lamivudinum (Latin)
• Lamivudin (German)
• Lamivudine (French)
• Lamivudina (Spanish)

Generic Names

• Lamivudine (OS: USAN, DCF, BAN)
• 3-TC (IS)
• GR 109714 X (IS: Glaxo)
• Lamivudine (PH: BP 2010, Ph. Eur. 6, Ph. Int. 4, USP 32)
• Lamivudinum (PH: Ph. Eur. 6)

Brand Names

• 3 TC
  GlaxoSmithKline, Argentina



• 3TC
  GlaxoSmithKline, Australia; GlaxoSmithKline, Aruba; GlaxoSmithKline, Canada; GlaxoSmithKline, Colombia; GlaxoSmithKline, Guyana; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Indonesia; GlaxoSmithKline, Mexico; GlaxoSmithKline, Malaysia; GlaxoSmithKline, New Zealand; GlaxoSmithKline, Taiwan; GlaxoSmithKline, South Africa; Muscat, Oman; ViiV, Switzerland



• 3TC-HBV
  GlaxoSmithKline, Indonesia



• Adco-Lamivudine
  Adcock Ingram Pharmaceuticals, South Africa



• Amilitrap
  Dosa, Argentina



• Aspen Lamivudine
  Aspen Pharmacare, South Africa



• Aspen Lamzid (Lamivudine and Zidovudine)
  Aspen Pharmacare, South Africa



• Avilam
  Beximco, Bangladesh



• Avocomb (Lamivudine and Zidovudine)
  Ranbaxy Laboratories, Ethiopia



• Avolam
  Ranbaxy Laboratories, Ethiopia



• Ciplabudina
  Biotoscana, Colombia



• Cipla-Duovir (Lamivudine and Zidovudine)
  Cipla Medpro, South Africa



• Cipla-Lamivudine
  Cipla Medpro, South Africa



• Combid (Lamivudine and Zidovudine)
  GlaxoSmithKline, Thailand



• Combivir (Lamivudine and Zidovudine)
  Bracco, Italy; Glaxo Group, Austria; Glaxo Group, Bulgaria; Glaxo Group, Luxembourg; Glaxo SmithKline, Spain; GlaxoGroup, Netherlands; GlaxoSmithKline, Australia; GlaxoSmithKline, Belgium; GlaxoSmithKline, Bahrain; GlaxoSmithKline, Canada; GlaxoSmithKline, Colombia; GlaxoSmithKline, Germany; GlaxoSmithKline, Denmark; GlaxoSmithKline, Ethiopia; GlaxoSmithKline, Finland; GlaxoSmithKline, France; GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Hungary; GlaxoSmithKline, Ireland; GlaxoSmithKline, Japan; GlaxoSmithKline, Norway; GlaxoSmithKline, New Zealand; GlaxoSmithKline, Oman; GlaxoSmithKline, Peru; GlaxoSmithKline, Sweden; GlaxoSmithKline, Slovenia; GlaxoSmithKline, Slovakia; GlaxoSmithKline, South Africa; ViiV, Switzerland; ViiV Healthcare, United States



• Coviro (Lamivudine and Stavudine)
  Ranbaxy, Myanmar



• Diavix (Lamivudine and Zidovudine)
  Beximco, Bangladesh



• Duovir (Lamivudine and Zidovudine)
  Cipla, Ethiopia



• Duovox (Lamivudine and Zidovudin)
  Biotoscana, Peru



• Emduo (Lamivudine and Stavudine)
  Emcure, Myanmar



• Emtri (Lamivudine and Stavudine, + Nevirapine)
  Emcure, Myanmar



• Epivir 3TC
  GlaxoSmithKline, Chile; GlaxoSmithKline, Russian Federation



• Epivir
  Glaxo Group, Austria; Glaxo Group, Luxembourg; Glaxo SmithKline, Spain; Glaxo Wellcome, Portugal; Glaxo Wellcome, Slovenia; Glaxo Wellcome, Tunisia; GlaxoGroup, Netherlands; GlaxoSmithKline, United Arab Emirates; GlaxoSmithKline, Belgium; GlaxoSmithKline, Bahrain; GlaxoSmithKline, Brazil; GlaxoSmithKline, Czech Republic; GlaxoSmithKline, Germany; GlaxoSmithKline, Denmark; GlaxoSmithKline, Ethiopia; GlaxoSmithKline, Finland; GlaxoSmithKline, France; GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Greece; GlaxoSmithKline, Croatia (Hrvatska); GlaxoSmithKline, Hungary; GlaxoSmithKline, Ireland; GlaxoSmithKline, Israel; GlaxoSmithKline, Iran; GlaxoSmithKline, Iceland; GlaxoSmithKline, Italy; GlaxoSmithKline, Japan; GlaxoSmithKline, Kuwait; GlaxoSmithKline, Norway; GlaxoSmithKline, Oman; GlaxoSmithKline, Peru; GlaxoSmithKline, Qatar; GlaxoSmithKline, Romania; GlaxoSmithKline, Serbia; GlaxoSmithKline, Sweden; GlaxoSmithKline, Singapore; GlaxoSmithKline, Slovakia; GlaxoSmithKline, Thailand; GlaxoSmithKline, Turkey; GlaxoSmithKline, Venezuela; ViiV Healthcare, United States



• Epivir-HBV
  ViiV Healthcare, United States



• Epzicom (Lamivudine and Abacavir)
  GlaxoSmithKline, Japan; ViiV Healthcare, United States



• Flamivud
  Flamingo Pharmacueticals, Ethiopia



• Ganvirel
  Ivax, Argentina



• Hepadin
  Amico, Bangladesh



• Hepavir
  Square, Bangladesh



• Hepitec
  GlaxoSmithKline, India



• Heptodin
  GlaxoSmithKline, China



• Heptodine
  GlaxoSmithKline, Argentina



• Heptovir
  GlaxoSmithKline, Canada



• Hivarif
  Square, Bangladesh



• Imunoxa
  Gador, Argentina



• Inhavir
  Biogen, Colombia; Biogen, Peru



• Kess
  Filaxis, Argentina



• Kivexa (Lamivudine and Abacavir)
  Glaxo Group, Austria; Glaxo SmithKline, Spain; GlaxoGroup, Netherlands; GlaxoSmithKline, Australia; GlaxoSmithKline, Belgium; GlaxoSmithKline, Canada; GlaxoSmithKline, Germany; GlaxoSmithKline, Denmark; GlaxoSmithKline, France; GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Greece; GlaxoSmithKline, Croatia (Hrvatska); GlaxoSmithKline, Hungary; GlaxoSmithKline, Ireland; GlaxoSmithKline, Italy; GlaxoSmithKline, Norway; GlaxoSmithKline, New Zealand; GlaxoSmithKline, Portugal; GlaxoSmithKline, Sweden; GlaxoSmithKline, Slovenia; GlaxoSmithKline, South Africa; ViiV, Switzerland



• Ladiwin
  Cadila, Ghana; Cadila, Kenya; Cadila, Malawi; Cadila, Nigeria; Cadila, Sudan; Cadila, Tanzania; Cadila, Uganda; Cadila, Zambia; Cadila Health Care, Ethiopia; Zydus Cadila, India



• Lamibergen
  Paylos, Argentina



• Lamidac
  Cadila Health Care, Ethiopia; Zydus Cadila, India; Zydus Cadila, Myanmar



• Lamidin
  Eskayef, Bangladesh; Medibios Laboratories, Ethiopia



• Lamilea
  Elea, Argentina



• Lamimac
  Macleods Pharmaceuticals, Ethiopia



• Lamitec
  Zifam India, Myanmar



• Lamitec-S (Lamivudine and Stavudine)
  Zifam India, Myanmar



• Lamivir
  Cipla, Georgia; Cipla, India; Flamingo Pharmacueticals, Ethiopia; Incepta, Bangladesh; Pharmaceutical, Venezuela



• Lamivox
  Aurobindo Pharma, Ethiopia; Biotoscana, Peru



• Lamivudin Stada
  Stada, Vietnam



• Lamivudina Delta
  Delta Farma, Argentina



• Lamivudina Microsules
  Microsules, Argentina



• Lamivudina
  Induquimica, Peru



• Lamivudine
  InvaGen, United States



• Lamivur
  Cipla, Ethiopia



• Lamuzid (Lamivudine and Zidovudine)
  Cadila Health Care, Ethiopia; Zydus Cadila, Myanmar



• Lasovir (Lamivudine and Zidovudine)
  Zifam India, Myanmar



• Lavir
  Emcure, Myanmar



• Lazid (Lamivudine and Stavudine)
  Emcure, Myanmar



• Maxivir (Lamivudine and Stavudine, + Nevirapine)
  Okasa, Myanmar



• Medilam (Lamivudine and Stavudine)
  Meditab, Myanmar



• Medivir (Lamivudine and Zidovudine)
  Meditab, Myanmar



• Oralmuv
  LKM, Argentina



• Sonke-LamiNevStav (Lamivudine and Nevirapine, + Stavudine)
  Ranbaxy, South Africa



• Sonke-Lamivudine + Zidovudine (Lamivudine and Zidovudine)
  Ranbaxy, South Africa



• Sonke-Lamivudine
  Ranbaxy, South Africa



• Triomune (Lamivudine and Stavudine, + Nevirapine)
  Cipla Medpro, South Africa



• Triovix (Lamivudine and Zidovudine)
  Beximco, Bangladesh



• Trizivir (Lamivudine and Abacavir, + Zidovudine)
  Glaxo Group, Austria; Glaxo SmithKline, Spain; Glaxo Wellcome, Bulgaria; GlaxoGroup, Netherlands; GlaxoSmithKline, Australia; GlaxoSmithKline, Belgium; GlaxoSmithKline, Canada; GlaxoSmithKline, Colombia; GlaxoSmithKline, Germany; GlaxoSmithKline, France; GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Ireland; GlaxoSmithKline, Norway; GlaxoSmithKline, Oman; GlaxoSmithKline, Sweden; GlaxoSmithKline, Turkey; GlaxoSmithKline, South Africa; Novo Nordisk, Denmark; Shire, Canada; ViiV, Switzerland; ViiV Healthcare, United States



• Trovir (Lamivudine and Zidovudine, + Nevirapine)
  Zifam India, Myanmar



• Viradin
  Healthcare, Bangladesh



• Virdual (Lamivudine and Zidovudine)
  Biogen, Colombia



• Virocomb (Lamivudine and Zidovudine)
  Ranbaxy, Myanmar



• Virocomb-N (Lamivudine and Nevirapine, + Zidovudine)
  Ranbaxy, Myanmar



• Virolans (Lamivudine and Nevirapine, + Stavudine)
  Ranbaxy, Myanmar



• Virozen (Lamivudine and Stavudine, + Nevirapine)
  Zifam India, Myanmar



• Vuclodir
  Richmond, Argentina; Richmond, Peru



• Vudin
  Alco, Bangladesh



• Zeffix
  Glaxo Group, Austria; Glaxo Group, Luxembourg; Glaxo Group, Poland; Glaxo Group Limited-GB, Italy; Glaxo SmithKline, Spain; Glaxo Wellcome, Portugal; Glaxo Wellcome, Slovenia; Glaxo Wellcome, Tunisia; GlaxoGroup, Netherlands; GlaxoSmithKline, Australia; GlaxoSmithKline, Bosnia & Herzegowina; GlaxoSmithKline, Bangladesh; GlaxoSmithKline, Belgium; GlaxoSmithKline, Switzerland; GlaxoSmithKline, Czech Republic; GlaxoSmithKline, Germany; GlaxoSmithKline, Denmark; GlaxoSmithKline, Finland; GlaxoSmithKline, France; GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Greece; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Croatia (Hrvatska); GlaxoSmithKline, Hungary; GlaxoSmithKline, Ireland; GlaxoSmithKline, Israel; GlaxoSmithKline, Sri Lanka; GlaxoSmithKline, Myanmar; GlaxoSmithKline, Malaysia; GlaxoSmithKline, Norway; GlaxoSmithKline, New Zealand; GlaxoSmithKline, Oman; GlaxoSmithKline, Philippines; GlaxoSmithKline, Romania; GlaxoSmithKline, Serbia; GlaxoSmithKline, Russian Federation; GlaxoSmithKline, Sweden; GlaxoSmithKline, Singapore; GlaxoSmithKline, Slovakia; GlaxoSmithKline, Thailand; GlaxoSmithKline, Turkey; GlaxoSmithKline, Taiwan; GlaxoSmithKline, Vietnam



• Zefix
  GlaxoSmithKline, Japan

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
IUPAC	International Union of Pure and Applied Chemistry
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.